Literature DB >> 34618262

Complex Interaction of Platelets, von Willebrand Factor and Leukocytes, in Whole Blood at High Shear Rates Is Mediated by Platelet GPIIb/IIIa Receptor.

Yu N Avtaeva1, I S Mel'nikov2, O S Saburova2, K G Guriya2, M C Osidak2, C P Domogatsky2, Z A Gabbasov2.   

Abstract

We studied the contribution of von Willebrand factor (vWF) into blood cell adhesion to collagen-coated surfaces in whole blood of healthy volunteers. Adhesion of blood cells to collagen I was measured at shear rate of 2300 sec-1. The interaction of platelet GPIIb/IIIa receptor with vWF was blocked with monoclonal anti-GPIIb/IIIa antibodies. The degree of cell adhesion was quantified by measuring the intensity of scattered light after 15-min perfusion: in samples with blocked GPIIb/IIIa it decreased to 0.39±0.13 V vs 0.06±0.03 V in control samples (p=0.002). Under a fluorescence microscope, intensively stained structures consisting of vWF, platelets, and leukocytes attached to the collagen surface were observed. After blockade of GPIIb/IIIa, these structures were absent. Leukocyte recruitment at high shear rates is a time-dependent process sensitive to complex interaction of vWF, leukocytes, and platelets, in which the platelet GPIIb/IIIa receptor is essential.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  GPIIb/IIIa; high shear rates; leukocytes; platelets; von Willebrand factor

Mesh:

Substances:

Year:  2021        PMID: 34618262     DOI: 10.1007/s10517-021-05274-5

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  9 in total

1.  Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress.

Authors:  A Bernardo; C Ball; L Nolasco; H Choi; J L Moake; J F Dong
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

2.  von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain.

Authors:  Changjie Zhang; Anju Kelkar; Sriram Neelamegham
Journal:  Blood Adv       Date:  2019-04-09

3.  Real-Time Recording of Platelet Adhesion to Fibrinogen-Coated Surface under Flow Conditions.

Authors:  Yu N Avtaeva; I S Mel'nikov; Z A Gabbasov
Journal:  Bull Exp Biol Med       Date:  2018-05-24       Impact factor: 0.804

Review 4.  Ischaemic stroke: a thrombo-inflammatory disease?

Authors:  Bernhard Nieswandt; Christoph Kleinschnitz; Guido Stoll
Journal:  J Physiol       Date:  2011-07-18       Impact factor: 5.182

5.  Platelets as key players in inflammation and infection.

Authors:  Leo Nicolai; Steffen Massberg
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.284

6.  von Willebrand factor promotes leukocyte extravasation.

Authors:  Björn Petri; Andre Broermann; Hang Li; Alexander G Khandoga; Alexander Zarbock; Fritz Krombach; Tobias Goerge; Stefan W Schneider; Claire Jones; Bernhard Nieswandt; Martin K Wild; Dietmar Vestweber
Journal:  Blood       Date:  2010-08-17       Impact factor: 22.113

Review 7.  von Willebrand factor and inflammation.

Authors:  C Kawecki; P J Lenting; C V Denis
Journal:  J Thromb Haemost       Date:  2017-07       Impact factor: 5.824

Review 8.  The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.

Authors:  Felice Gragnano; Simona Sperlongano; Enrica Golia; Francesco Natale; Renatomaria Bianchi; Mario Crisci; Fabio Fimiani; Ivana Pariggiano; Vincenzo Diana; Andreina Carbone; Arturo Cesaro; Claudia Concilio; Giuseppe Limongelli; Mariagiovanna Russo; Paolo Calabrò
Journal:  Mediators Inflamm       Date:  2017-05-28       Impact factor: 4.711

Review 9.  Inflammation, von Willebrand factor, and ADAMTS13.

Authors:  Junmei Chen; Dominic W Chung
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

  9 in total
  1 in total

1.  Noonan syndrome with RAF1 gene mutations in a newborn with cerebral haemorrhage.

Authors:  Junwei Lan; Tianbao Zeng; Sheng Liu; Juhong Lan; Lijun Qian
Journal:  Eur J Med Res       Date:  2022-08-11       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.